Incyte | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 3.38B 111M 2024-12
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 238.09M 68.45M 2025-03
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 3.46B 2.08B 2025-03
Exelixis USD 230.42M 24.72M 2025-06
Gilead Sciences USD 2.96B 112M 2024-12
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
MacroGenics USD -14477000 70.79M 2024-12
Merck USD 6.77B 864M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 730.4M 585.6M 2025-03


Incyte L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.